NEUROTENSINERGIC AGONISTS AND METHODS OF USING SAME PREVENTING OR TREATING PAIN

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTS

Peptides and T cells for use in immunotherapeutic treatment of various cancers

Di-sulfide containing cell penetrating peptides and methods of making and using thereof

METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS

Integrin antagonists

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptide inhibitors targeting the CXCL12/HMGB1 interaction and uses thereof

MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING A NEUROLOGICAL CONDITION

Tumor targeting polypeptide and method of use thereof

Cancer Antigen Peptide

Cancer Antigen Peptide

Cancer Antigen Peptide

Method for detection and quantification of CLN3 protein

Preparation method of anti-oxidation polypeptide

Artificial nucleases comprising engineered cleavage half-domains

POLYPEPTIDE HAVING ANTIBACTERIAL ACTIVITY, COMPOSITION FOR PREVENTING OR TREATING SEPSIS COMPRISING SAME, AND ANTIBACTERIAL COMPOSITION

Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof

Isolated peptide, anti-cancer medicinal composition including the same and method of specifically reducing or inhibiting activities of cancer cells using the same

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides having inhibitory activity on muscarinic receptor M3

Polypeptide tag, highly soluble recombinant nitrilase and application thereof in synthesis of pharmaceutical chemicals

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Soluble lipidated ligand agents for treating eye inflammation

Peptide and use thereof

GLYCOCALYX MIMETIC COATINGS

Compositions for treating pathological calcification conditions, and methods using same

Methods and products for in vivo enzyme profiling

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Desmoglein 2 (DSG2) binding proteins and uses therefor

MELANOCORTIN RECEPTOR LIGANDS

Compositions for preventing or treating viral and other microbial infections

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR INTEGRIN ALPHA-V-BETA-3

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Polypeptides and compositions comprising the same

BI-SPECIFIC EXTRACELLULAR MATRIX BINDING PEPTIDES AND METHODS OF USE THEREOF

PEPTIDE AND FOR TREATING INFLAMMATORY DISEASE AND PAIN USING THE SAME

BIOMARKERS AND TREATMENT OF NEURONAL INJURY AND NEURODEGENERATION

Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for use in medicine

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME

FOXM1-DERIVED PEPTIDE, AND VACCINE INCLUDING SAME

Branched peptides for enzymatic assembly and mitochondria drug delivery

Neuroprotective peptides

METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR

ACETYLCHOLINE RECEPTOR INHIBITORY PEPTIDES AND USES THEREOF

Neuroprotective peptides and methods of their use

Inhibitors of NF kappa-B activity for treatment of diseases and disorders

PSMA-TARGETED NIR DYES AND THEIR USES

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS

COMPOSITION FOR DELIVERY OF GENETIC MATERIAL

PEPTIDE TAGS FOR LIGAND INDUCED DEGRADATION OF FUSION PROTEINS

Selective recovery

CYCLIC PEPTIDE, CELL SCAFFOLD MATERIAL, CELL SEPARATING MATERIAL, AND MEDIUM

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS

Transfection complexes and methods of using the same

ANTIMICROBIAL PEPTIDES

Peptide oligonucleotide conjugates

Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Immunotherapy against several tumors including lung cancer

Composite polypeptide having a metal binding motif and molecular construct comprising the same

NOVEL PEPTIDES AND USES THEREOF

Selective CXCR4 binding peptide conjugate and methods for making and using the same

ANTIBODIES TO MISFOLDED TDP-43 AND METHODS OF USE

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

METHOD FOR TREATING OPIOID USE DISORDER

IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Anti-inflammatory nanofibers

Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Variable lymphocyte receptors that target the brain extracellular matrix and methods of use

Compound and angiogenic agent comprising same

CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS

MITOCHONDRIA-TARGETING PEPTIDES

Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Peptides and combination of peptides for use in immunotherapy against various tumors

VIRALLY EXPRESSED INHIBITORS OF PDZ DOMAINS, SUCH AS PICK1 AND USES THEREOF

Tumor-specific polypeptide and use thereof

Anti-microbial peptides

Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of colorectal cancer

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

PEPTIDES COMPRISING OPIOID RECEPTOR AGONIST AND NK1 RECEPTOR ANTAGONIST ACTIVITIES

Alpha-v beta-6 integrin ligands and uses thereof

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

Compositions comprising circular polyribonucleotides and uses thereof

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides for inducing bacteriocin synthesis and methods to identify and/or select and/or optimize the same

GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES

CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Immunotherapy against several tumors including gastrointestinal and gastric cancer

METHODS OF SELECTING FUNCTIONAL INTERFACE MIMICS, AND COMPOSITIONS THEREOF

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY

BLOOD-BRAIN BARRIER PERMEABLE PEPTIDE

PEPTIDE LIGANDS FOR CAPTURE OF HOST CELL PROTEINS

Heat Shock Protein-Binding Peptide Compositions And Methods Of Use Thereof

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER

Peptides and combination of peptides for use in immunotherapy against various tumors

Fusion peptides as antimicrobial agents

PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES

PEPTIDOMIMETIC MACROCYCLES

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

BI-FUNCTIONAL ARGININE-GLYCINE-ASPARTIC ACID (RGD) PEPTIDES AND METHODS TO PROMOTE ANGIOGENESIS

Liposome binding peptide, construct for manufacturing the liposome binding peptide, and liposome

Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody

Peptides, combination of peptides as targets and for use in immunotherapy

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptide probe for recognition of G-quadruplex and use thereof in detection of G-quadruplex in cell

Peptide compound, application thereof and composition containing same

IMMUNE CHECKPOINT INHIBITOR COMBINATIONS

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Compound and a method for identifying a protein using said compound

Peptide compounds for suppressing inflammation

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Ang (1-7) derivative oligopeptides and methods for using and producing the same

Biomimetic peptides derived from biological source and their uses in retarding aging and improving skin

MINI-NUCLEOSOME CORE PROTEINS AND USE IN NUCLEIC ACID DELIVERY

NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME

Personalized immunotherapy against several neuronal and brain tumors

Method for isolating exosome and exosome isolation kit

CRISPR-BASED GENOME MODIFICATION AND REGULATION

Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses

Treatments for Gastrointestinal Disorders

Pharmacokinetics and cholecystokinin-2 receptor (CCK2R) targeting for diagnosis and therapy

NEUTRAL MULTIDOMAIN PEPTIDE HYDROGELS AND USES THEREOF

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

CHIMERIC ANTIGEN RECEPTOR SPACERS

SARS-CoV-2 epitope-targeted peptide immunostimulants

Cationic peptides for activating Lck

α4β7 thioether peptide dimer antagonists

Peptide having cytoprotective effect against environmental pollutant and use thereof

Modified Netrin-1 Peptides and Compositions for Cardioprotection

CDCA1-DERIVED PEPTIDE AND VACCINE CONTAINING SAME

Tertiary amino lipidated cationic peptides for nucleic acid delivery

Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery

Compound for the sequestration of undesirable antibodies in a patient

Personalized immunotherapy against several neuronal and brain tumors

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

Biorecognition elements for detection of fungi and bacteria in fuel systems

LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

METHOD FOR SOLUBLE EXPRESSION AND PURIFICATION OF HYDROPHOBIN

Therapeutic peptides

Compounds having RD targeting motifs and methods of use thereof

Peptides and combination of peptides for use in immunotherapy against various cancers

CD31SHED AS A MOLECULAR TARGET FOR IMAGING OF INFLAMMATION

Method for removing water from compound solution and performing conjugate acid conversion

Immunotherapy against several tumors including neuronal and brain tumors

INHIBITORS OF PICK1 AND USES THEREOF

Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis

Peptides and combination of peptides for use in immunotherapy against various cancers

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Immunotherapy against several tumors including gastrointestinal and gastric cancer

METHODS FOR IDENTIFYING CHIMERIC ANTIGEN RECEPTOR-TARGETING LIGANDS AND USES THEREOF

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Antimicrobial peptide AS-hepc3of and method thereof

NONAPEPTIDE PREVENTING INCREASED HYPERPERMEABILITY OF VASCULAR ENDOTHELIUM

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

In vivo protein N-acylation

Netrin-1 Compounds and Compositions Thereof for Treating Pulmonary Hypertension

Albumin binding peptide conjugates and methods thereof

A*03 restricted peptides for use in immunotherapy against cancers and related methods

A*03 restricted peptides for use in immunotherapy against cancers and related methods

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

SPECIFIC MURINE AND HUMANIZED MONOCLONAL ANTIBODIES DETECTING PATHOLOGY ASSOCIATED SECONDARY STRUCTURE CHANGES IN PROTEINS AND PEPTIDES

Beta-Arrestin Effectors and Compositions and Methods of Use Thereof

Peptides for the treatment of covid-19

LIPID NANOPARTICLE FORMULATIONS COMPRISING LIPIDATED CATIONIC PEPTIDE COMPOUNDS FOR NUCLEIC ACID DELIVERY

Methods for Reducing Perinatal Morbidity and / or Mortality

Peptides and combination thereof for use in the immunotherapy against cancers

MELANIN-PEPTIDE-BASED PHOTONIC MATERIALS

Anti-inflammatory use of peptide

ZP3 FRAGMENTS IN IMMUNOTHERAPY OF OVARIAN CANCER

Uterine cancer treatments

COMPOSITIONS AND METHODS FOR TREATING CD40-MEDIATED DISEASES

Conjugates of montelukast and peptides

NPP1 FUSION PROTEINS

Uterine cancer treatments

NOVEL PEPTIDES AND ITS DERIVATIVES CAPABLE OF STIMULATING CYTOKINE RELEASE

CYCLIC PEPTIDES TARGETING ALPHA-4-BETA-7 INTEGRIN

Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof

Heterotandem bicyclic peptide complexes

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

Encryption device and operation method thereof

Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders

CBX8 CHROMDOMAIN INHIBITORS AND THE USES THEREOF

Fusion protein with half-life extending polypeptide

Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery

MUCUS-PENETRATING PEPTIDES AND SCREENING ASSAY

Peptides and combination of peptides for use in immunotherapy against various cancers

CELL LINKERS FOR HETEROTYPIC CELL SPHEROIDS

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

B*44 restricted peptides for use in immunotherapy against cancers and related methods

PLANT-DERIVED ELASTIN BINDING PROTEIN LIGANDS AND METHODS OF USING THE SAME

14-3-3 targeting peptides for cancer treatment

Stabilized minimal coiled-coil mimetics

Melanocortin-1-receptor agonists

PD-1 and CTLA-4 Dual Inhibitor Peptides

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Compositions comprising circular polyribonucleotides and uses thereof

USE OF CYCLOSPORINE ANALOGUES FOR TREATING CANCER

ADJUVANT FOR CELL CULTURE

Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Methods and compositions for the identification of epithelial to mesenchymal breast cancer

Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)

Isolated darobactin A analog compounds and compositions thereof

Peptide compounds and therapeutic uses of same

Immunotherapy against several tumors including neuronal and brain tumors

LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT

Immunotherapy against several tumors including gastrointestinal and gastric cancer

Dry powder formulation of caveolin-1 peptides and methods of use thereof

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

Immunotherapy against several tumors including lung cancer

Proteogenomic-based method for identifying tumor-specific antigens

Immunotherapy against several tumors including neuronal and brain tumors

Tandem repeat cancer-targeting peptides for molecular conjugation or engineering and uses thereof in cancer theranostics

PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF

PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

Method for mediating targeted delivery of a composition to the brain of a subject in need thereof

Protein interfaces

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Fusion protein bound to cell-permeable peptide, and composition comprising fusion protein or cell-permeable peptide and epithelial cell growth factor as active ingredients

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

Peptides for specific inhibition of Jag 1-Notch 1 pathway

Modulation of complement activity

Composition for muscle relaxation

PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF

Peptoid compound and preparation method, carrier, and pharmaceutical composition thereof

Methods and Systems for Measuring Plasma Renin Activity

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

PEPTIDE FOR DISEASE TREATMENT

Immunotherapy against several tumors including neuronal and brain tumors

Biomaterials for 3D Cell Growth and Differentiation

B*44 restricted peptides for use in immunotherapy against cancers and related methods

Selenium-chelating pea oligopeptide, and preparation method and use thereof

CAR-T cells targeting glioma stem cells for the treatment of glioblastoma multiforme

Artificially synthesized peptide H-473 and use thereof

Personalized immunotherapy against several neuronal and brain tumors

METHODS FOR PROTEOMIC PROFILING USING NON-NATURAL AMINO ACIDS

Arid5a peptide inhibitors

Heterochiral peptide-complex and composition for measuring nuclear magnetic resonance spectroscopy residual dipolar coupling containing self-assembled intermediates of heterochiral peptide-complex

EPHA2 agonists and uses thereof

Peptide docking vehicle for targeted nucleic acid delivery

Peptide, method and composition for melanin polymerization and hair darkening

ALZHEIMER'S DISEASE TREATMENT METHOD

Method of removing lipopeptides from solutions and changing their structure

Peptides having octopus octopressin activity and use thereof

Peptide activating agent

Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers

CRISPR-BASED GENOME MODIFICATION AND REGULATION

Bi-terminal pegylated integrin-binding peptides and methods of use thereof

Therapeutic compositions including peptides and uses thereof

Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the same

Peptide for preventing skin damage caused by air pollutants and for anti-aging, and use thereof

Anti-Tumour Response to Modified Self-Epitopes

EphA2 T-cell epitope agonists and uses therefore

Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor

REACTIVE OXYGEN PRODUCTION INHIBITOR AND/OR SCAVENGING PROMOTER

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

Cancer-specific T-cell receptors

PEPTIDES FOR USE IN PROMOTING TRANSPORT OF GLUCOSE